Citations

Clear

2358 citation(s) found for "Yu, Long".

Association Between Surgical Technical Skill and Long-term Survival for Colon Cancer
Stulberg, Jonah J. , Palis, Bryan E., Chung, Jeanette W. , Huang, Reiping , Nelson, Heidi , Bilimoria, Karl Y. , Brajcich, Brian C.

Mayo Clinic

JAMA Oncology | October 30, 2020 | Volume: 7 | Issue: 1 | Pages: 127

10.1001/jamaoncol.2020.5462 | PMID 33125472 Get It

Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation
Azad, Adiba , Rosen, Charles B. , Taner, Timuçin , Gores, Gregory J. , Gores, Gregory J. , Azad, Adiba I, Azad, Adiba I , Heimbach, Julie K.

Mayo Clinic

Cancers | October 29, 2020 | Volume: 12 | Issue: 11 | Pages: 3157

10.3390/cancers12113157 | PMID 33121179 Get It

Selected patients with unresectable perihilar cholangiocarcinoma (pCCA) derive long-term benefits from liver transplantation. Between 1993–2019, our group at Mayo Clinic performed 237 transplants for pCCA. With this experience, we note that two distinct patient populations comprise this group of pCCA patients: those with underlying primary sclerosing cholangitis (PSC) and those without identifiable risk factors termed sporadic or de novo pCCA. Long-term survival after transplant is better in PSC patients (74% five-year survival) than in those with de novo pCCA (58% five-year survival). Herein, we review the likely clinical factors contributing to the divergence in outcomes for these two patient populations. We also offer our insights on how further advances may improve patient selection and survival, focusing on the de novo pCCA patient population.
Second victim experiences of nurses in obstetrics and gynaecology: A Second Victim Experience and Support Tool Survey
Finney, Robyn E. , Torbenson, Vanessa E. , Weaver, Amy L. , Long, Margaret E. , Allyse, Megan , Allyse, Megan A , Rivera-Chiauzzi, Enid Y , Riggan, Kirsten A. , Rivera‐Chiauzzi, Enid Y.

Mayo Clinic

Journal of Nursing Management | October 28, 2020 | Volume: 29 | Issue: 4 | Pages: 642-652

10.1111/jonm.13198 | PMID 33113207 Get It

Feed-forward, feed-back, and distributed feature representation during visual word recognition revealed by human intracranial neurophysiology
Long, Laura, Yang, Minda, Kriegeskorte, Nikolaus , Jacobs, Joshua , Sperling, Michael R. , Sharan, Ashwini , Burks, Alexis, Gross, Robert A. , Sheth, Sameer A. , Gorniak, Richard , Wanda, Paul A., Kahana, Michael J. , Mesgarani, Nima , Sperling, Michael R , Long, Laura, Remez, Robert E. , Lega, Bradley Charles , Burks, Alexis, Worrell, Gregory A. , Jobst, Barbara C. , Davis, Kathryn A. , Zaghloul, Kareem A. , Stein, Joel M. , Das, Sandhitsu R.

Mayo Clinic

No container title available | October 26, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-95141/v1 Get It

Abstract Scientists debate where, when, and how different visual, orthographic, lexical, and semantic features are involved in visual word recognition. In this study, we investigate intracranial neurophysiology data from 151 patients engaged in reading single words. Using representational similarity analysis, we characterize the neural representation of a hierarchy of word features across the entire cerebral cortex. We find evidence of both feed-forward and feedback processing, with early representation of visual and lexical information in lingual gyrus followed by lexical representation in fusiform gyrus and semantic sensitivity in inferior frontal gyrus, with letter representation emerging later in fusiform gyrus. Furthermore, we observed a variety of anatomically heterogeneous temporal response shapes, and these functional populations had significant feature sensitivity. Taken together, our results demonstrate the early influence of lexical, phonological, and semantic features in visual word recognition and reveal feed-forward, feed-back, and anatomically distributed processing mechanisms that contribute to visual word recognition.
S0348 Long-Term Outcomes and Predictors of Survival in Patients Undergoing Barrett’s Esophagus Surveillance
Hanada, Yuri , Hoefnagel, Sanne , Linn, Bryan, Mangels-Dick, Tiffany, Ghosh, Prithwish , Iyer, Prasad G. , Buttar, Navtej , Song, Louis Wong Kee, Wang, Kenneth K.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2020 | Volume: 115 | Issue: 1 | Pages: S171-S171

10.14309/01.ajg.0000703440.25420.10 Get It

Cardiopoietic Stem Cell Therapy in Ischaemic Heart Failure: Long-Term Clinical Outcomes
Behfar, Atta , Sanz‐Ruiz, Ricardo , Sherman, Warren, Heyndrickx, Guy R. , Metra, Marco , Filippatos, Gerasimos , Henry, Timothy D. , Hajjar, Roger J. , Tendera, Michał , Senger, Stefanie , Povsic, Thomas J. , Program, for the CHART, Behfar, Atta , Metra, Marco , Bartúnek, Jozef , Terzic, André , Davison, Beth A. , Wojakowski, Wojciech , Waldman, Scott A. , Teerlink, John R , Gersh, Bernard J. , Cotter, Gad , Wijns, William , Program, for the CHART

Mayo Clinic

ESC Heart Failure | October 23, 2020 | Volume: 7 | Issue: 6 | Pages: 3345-3354

10.1002/ehf2.13031 | PMID 33094909 Get It

Abstract Aims This study aims to explore long-term clinical outcomes of cardiopoiesis-guided stem cell therapy for ischaemic heart failure assessed in the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial. Methods and results CHART-1 is a multinational, randomized, and double-blind trial conducted in 39 centres in heart failure patients (n = 315) on standard-of-care therapy. The ‘active’ group received cardiopoietic stem cells delivered intramyocardially using a retention-enhanced catheter. The ‘control’ group underwent patient-level sham procedure. Patients were followed up to 104 weeks. In the entire study population, results of the primary hierarchical composite outcome were maintained neutral at Week 52 [Mann–Whitney estimator 0.52, 95% confidence interval (CI) 0.45–0.59, P = 0.51]. Landmark analyses suggested late clinical benefit in patients with significant left ventricular enlargement receiving adequate dosing. Specifically, beyond 100 days of follow-up, patients with left ventricular end-diastolic volume of 200–370 mL treated with ≤19 injections of cardiopoietic stem cells showed reduced risk of death or cardiovascular hospitalization (hazard ratio 0.38, 95% CI 0.16–0.91, P = 0.031) and cardiovascular death or heart failure hospitalization (hazard ratio 0.28, 95% CI 0.09–0.94, P = 0.040). Cardiopoietic stem cell therapy was well tolerated long term with no difference in safety readouts compared with sham at 2 years. Conclusions Longitudinal follow-up documents that cardiopoietic stem cell therapy is overall safe, and post hoc analyses suggest benefit in an ischaemic heart failure subpopulation defined by advanced left ventricular enlargement on tolerable stem cell dosing. The long-term clinical follow-up thus offers guidance for future targeted trials.
Proton extrusion during oxidative burst in microglia exacerbates pathological acidosis following traumatic brain injury
Ritzel, Rodney M. , He, Junyun , Li, Yun , Cao, Tuoxin , Khan, Niaz , Shim, Bosung, Sabirzhanov, Boris, Aubrecht, Taryn G., Stoica, Bogdan A. , Faden, Alan I. , Wu, Long‐Jun , Wu, Junfang , Wu, Long-Jun

Mayo Clinic

Glia | October 22, 2020 | Volume: 69 | Issue: 3 | Pages: 746-764

10.1002/glia.23926 | PMID 33090575 Get It

Abstract Acidosis is among the least studied secondary injury mechanisms associated with neurotrauma. Acute decreases in brain pH correlate with poor long‐term outcome in patients with traumatic brain injury (TBI), however, the temporal dynamics and underlying mechanisms are unclear. As key drivers of neuroinflammation, we hypothesized that microglia directly regulate acidosis after TBI, and thereby, worsen neurological outcomes. Using a controlled cortical impact model in adult male mice we demonstrate that intracellular pH in microglia and extracellular pH surrounding the lesion site are significantly reduced for weeks after injury. Microglia proliferation and production of reactive oxygen species (ROS) were also increased during the first week, mirroring the increase in extracellular ROS levels seen around the lesion site. Microglia depletion by a colony stimulating factor 1 receptor (CSF1R) inhibitor, PLX5622, markedly decreased extracellular acidosis, ROS production, and inflammation in the brain after injury. Mechanistically, we identified that the voltage‐gated proton channel Hv1 promotes oxidative burst activity and acid extrusion in microglia. Compared to wildtype controls, microglia lacking Hv1 showed reduced ability to generate ROS and extrude protons. Importantly, Hv1‐deficient mice exhibited reduced pathological acidosis and inflammation after TBI, leading to long‐term neuroprotection and functional recovery. Our data therefore establish the microglial Hv1 proton channel as an important link that integrates inflammation and acidosis within the injury microenvironment during head injury.
A Case Series of Long-Term Surgical Outcomes of Primary Pulmonary Artery Sarcomas With Opportunities for 3D-Printed Models in Surgical Planning
Mahajan, Nandita , Çïçek, Sertaç , McGregor, Christopher G.A. , Okuno, Scott H. , White, Darin , Yi, Eunhee S. , Mahajan, Nandita N , Çiçek, Sertaç M, Boland, Jennifer M. , Blackmon, Shanda H, Morris, Jonathan M. , Robinson, Steven I. , Blackmon, Shanda

Mayo Clinic

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery | October 20, 2020 | Volume: 16 | Issue: 1 | Pages: 94-100

10.1177/1556984520960716 | PMID 33076737 Get It

There are limited data regarding the surgical management of primary pulmonary artery sarcomas (PPAS) because of their rarity and complicated diagnostic history. The objective of this study was to analyze our institution’s long-term surgical management outcomes for PPAS in the absence of a care pathway. From May 1997 to June 2013, 8 patients (mean age 60.6 ± 11.8 years; range, 40-73 years; 5 women and 3 men) underwent surgical intervention for PPAS at our institution. The most common computed tomography finding was a luminal filling defect obstructing the pulmonary artery (PA), without evidence of extraluminal extension. Three patients underwent debulking/pulmonary endarterectomy alone and 5 patients underwent a more radical resection with PA patch angioplasty, PA resection and reconstruction, pulmonary valve replacement, and unilateral pneumonectomy. The mean postoperative survival in this series was 3.8 ± 3.6 years (range, 1-11.9 years), with 2 radical surgical resection patients alive at 4.9 and 11.9 years, respectively. For those patients with incomplete resection, 3-dimensional (3D) models were created to demonstrate the advantage of a preoperative guide for a more complete resection and what it would entail. Six patients had local recurrences with mean disease-free interval of 14 ± 10.9 months (range, 2 months-2.5 years), and 2 patients with re-resections had an overall postoperative survival of 2.8 and 11.9 years, respectively. In our small cohort of PPAS, patients treated with radical surgical resection had better survival. The small number of PPAS cases in this series makes proving this association unlikely but warrants consideration.
Long Term Dietary Restriction of Advanced Glycation End-Products (AGEs) in Older Adults with Type 2 Diabetes Is Feasible and Efficacious-Results from a Pilot RCT
Lotan, Roni , Ganmore, Ithamar , Shelly, Shahar , Zacharia, Moran, Uribarri, Jaime , Beisswenger, Paul J. , Cai, Weijing, Troen, Aron M. , Beeri, Michal Schnaider , Shahar, Shelly , Uribarri, Jaime

Mayo Clinic

Nutrients | October 15, 2020 | Volume: 12 | Issue: 10 | Pages: 3143

10.3390/nu12103143 | PMID 33076217 Get It

Introduction: High serum concentrations of advanced glycation end-products (AGEs) in older adults and diabetics are associated with an increased risk of cognitive impairment. The aim of this pilot study was to assess the feasibility of long-term adherence to a dietary intervention designed to decrease intake and exposure to circulating AGEs among older adults with type 2 diabetes. Methods: Herein, 75 participants were randomized to either a standard of care (SOC) control arm or to an intervention arm receiving instruction on reducing dietary AGEs intake. The primary outcome was a change in serum AGEs at the end of the intervention. Secondary and exploratory outcomes included adherence to diet and its association with circulating AGEs. Cognitive function and brain imaging were also assessed but were out of the scope of this article (ClinicalTrials.gov Identifier: NCT02739971). Results: The intervention resulted in a significant change over time in several serum AGEs compared to the SOC guidelines. Very high adherence (above 80%) to the AGE-lowering diet was associated with a greater reduction in serum AGEs levels. There were no significant differences between the two arms in any other metabolic markers. Conclusions: A long-term dietary intervention to reduce circulating AGEs is feasible in older adults with type 2 diabetes, especially in those who are highly adherent to the AGE-lowering diet.
Long non‑coding RNA expression profiles identify lncRNA‑XLOC_I2_006631 as a potential novel blood biomarker for Hashimoto's thyroiditis
Peng, Huiyong , Xiong, Si , Ding, Xiangmei, Tang, Xinyi , Wang, Xuehua , Wang, Li , Liu, Yingzhao

Mayo Clinic

International Journal of Molecular Medicine | October 13, 2020 | Volume: 46 | Issue: 6 | Pages: 2172-2184

10.3892/ijmm.2020.4755 | PMID 33125100 Get It